Hikma Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 5/6
Hikma Pharmaceuticals is a dividend paying company with a current yield of 3.48% that is well covered by earnings.
Key information
3.5%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 3.5% |
| Future Dividend Yield | 3.7% |
| Dividend Growth | 11.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | UK£0.790 |
| Payout ratio | 61% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: HIKL's dividends per share have been stable in the past 10 years.
Growing Dividend: HIKL's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Hikma Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (HIKL) | 3.5% |
| Market Bottom 25% (GB) | 2.1% |
| Market Top 25% (GB) | 5.9% |
| Industry Average (Pharmaceuticals) | 2.5% |
| Analyst forecast (HIKL) (up to 3 years) | 3.7% |
Notable Dividend: HIKL's dividend (3.48%) is higher than the bottom 25% of dividend payers in the UK market (2.14%).
High Dividend: HIKL's dividend (3.48%) is low compared to the top 25% of dividend payers in the UK market (5.85%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (61.2%), HIKL's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (46.2%), HIKL's dividend payments are well covered by cash flows.